Publications by authors named "Hiroshi Hatada"

Article Synopsis
  • The case report discusses a 64-year-old woman with IgG4-related sclerosing cholangitis who developed multiple intrahepatic artery aneurysms while on treatment.
  • Emergency procedures successfully treated the aneurysms, resolving her symptoms and stabilizing her condition.
  • The report highlights that hepatic artery aneurysms can be serious complications in patients with IgG4-SC, indicating a need for vigilant monitoring.
View Article and Find Full Text PDF
Article Synopsis
  • Nonalcoholic steatohepatitis (NASH) can lead to hepatocellular carcinoma (HCC), yet there are no established treatments, and a rare syndrome known as ROHHAD(NET) can complicate this condition.
  • The case study details the oldest known autopsy of a patient with ROHHAD(NET) who developed HCC, providing insights into the syndrome's progression and its relationship with NASH and HCC.
  • The patient experienced rapid obesity and other severe symptoms since childhood, was diagnosed with cirrhosis at 17 and HCC at 20, underwent treatment, but ultimately died from complications at age 21, with autopsy findings revealing significant necrosis of the cancer.
View Article and Find Full Text PDF

Hepatitis C virus (HCV) reactivation has been reported to be caused due to several anticancer drugs and immunosuppressive agents; however, HCV reactivation after steroid monotherapy has rarely been reported. Here, we report the case of a 65-year-old Japanese man with HCV infection who developed HCV reactivation after the administration of prednisolone (PSL) for 6 days for sudden deafness. In the patient history, the positivity for anti-HCV antibody was observed, but serum level of HCV RNA was not measured.

View Article and Find Full Text PDF
Article Synopsis
  • Comprehensive genomic profiling (CGP) using next-generation sequencing is enhancing precision medicine for advanced cancers, especially pancreatic cancers.
  • Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and biopsy (EUS-FNB) are critical techniques for diagnosing abdominal masses but face challenges with CGP success rates.
  • The article reviews the evolution from EUS-FNA to EUS-FNB, compares their effectiveness, and addresses current challenges in genomic analysis for hepatobiliary-pancreatic cancers.
View Article and Find Full Text PDF

An 82-year-old female patient was admitted to our hospital for visual acuity loss in both eyes. The patient was diagnosed with invasive liver abscess syndrome and bilateral endophthalmitis due to Klebsiella pneumoniae 4 days after the onset of ocular symptoms. The liver abscess improved by broad-spectrum antibiotics and intravitreal injection, but bilateral blindness occurred.

View Article and Find Full Text PDF

Rationale: Hepatocellular carcinoma (HCC) is the sixth most common type of cancer globally. Since 2020, combination treatment with atezolizumab and bevacizumab were approved in patients with unresectable HCC in Japan, and atezolizumab plus bevacizumab is the first-line treatment for unresectable HCC.

Patient Concerns: A 73-year-old Japanese man diagnosed with a large HCC was treated with atezolizumab plus bevacizumab.

View Article and Find Full Text PDF

Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of a 60-year-old man with short bowel syndrome who developed hematochezia due to panitumumab-induced colitis with vitamin K deficiency during third-line chemotherapy. The cause of vitamin K deficiency was the lack of intravenous vitamin K supplementation following a change from central venous nutrition to peripheral venous nutrition.

View Article and Find Full Text PDF

Pancreatic metastasis from renal cell carcinoma (RCC) is relatively rare. Surgical resection of the lesion is recommended if no residual tumor remains. Although there is no clear standard for surgical procedures, enucleation can be considered for small lesions.

View Article and Find Full Text PDF

A 66-year-old man was admitted to our department with hypercalcemia, pancreatic and liver tumors, and periportal lymph node enlargement. Contrast-enhanced computed tomography revealed a tumor in the pancreatic tail and the right hepatic lobe along with periportal lymphadenopathy. Laboratory data revealed hypercalcemia and high serum parathyroid hormone-related protein (PTHrP) levels.

View Article and Find Full Text PDF
Article Synopsis
  • A rare case of acute immune-mediated colitis with esophageal disorders (specifically esophagitis and ulcer) following pembrolizumab treatment for lung adenocarcinoma is reported.
  • This combination of gastrointestinal issues has not been documented in previous reports, making it a unique case.
  • The article includes a detailed description of the case along with a review of related literature to provide context.
View Article and Find Full Text PDF